|
Related Party Transactions
|
6 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2013
|
|||
| Related Party Transactions [Abstract] | |||
| Related Party Transactions Disclosure [Text Block] | 11. Related Party Transactions
In January 2012, the Company entered into an agreement with a vendor in which iBio’s President is a minority stockholder. The vendor performs laboratory feasibility analyses of gene expression, protein purification and preparation of research samples. The transaction has been conducted on an arm’s length basis at market terms. The accounts payable balance includes amounts due this vendor of approximately $92,000 and $93,000 at December 31, 2013 and June 30, 2013, respectively. Research and development expenses related to this vendor were approximately $153,000 and $124,000 for the three months ended December 31, 2013 and 2012, respectively, and approximately $306,000 and $219,000 for the six months ended December 31, 2013 and 2012, respectively. |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|